Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy
Clinical trial NCT03382574 · TERMINATED
Trial details
- NCT number
- NCT03382574
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-14
- Primary completion
- 2021-10-22
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.